(R)-Levetiracetam
CAS: 103765-01-1
Ref. 3D-DEA76501
1mg | 400,00 € | ||
2mg | 640,00 € | ||
5mg | 1.017,00 € | ||
10mg | 1.786,00 € | ||
25mg | 2.806,00 € |
Produktinformation
- (2R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-2-(2-Oxopyrrolidin-1-yl)butanamide
- (R)-Etiracetam
- (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide,a-ethyl-2-oxo-, (R)-
- Ucb-L 060
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)-
Levetiracetam is an antiepileptic drug that belongs to the class of drugs known as pyrrolidone derivatives. It is approved for the treatment of partial seizures, myoclonic seizures, and generalized tonic-clonic seizures. Levetiracetam binds to synaptic vesicle protein 2A at the same site as levetiracetam and prevents the release of neurotransmitters from nerve cells. This binding leads to neuronal death by inhibiting mitochondrial functions and reducing neuronal excitability by blocking voltage-sensitive sodium channels. Levetiracetam has been shown to have a concentration-time curve that is similar to intravenous anaesthetics in animal models. This drug also has a polymerase chain reaction (PCR) assay that can detect whether levetiracetam is present in urine samples; this test can be used as an aid in forensic investigations.
Chemische Eigenschaften
Technische Anfrage zu: 3D-DEA76501 (R)-Levetiracetam
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.